Remove 2025 Remove Networking Remove Training
article thumbnail

Big Data Steering Group to enhance data quality and discoverability under new workplan

European Pharmaceutical Review

The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.

Medicine 105
article thumbnail

EMA launches quality control group to aid medicine innovation

European Pharmaceutical Review

The body will ensure the European medicines regulatory network maintains momentum with innovation, recognises and addresses gaps in the regulatory framework and increases predictability for innovative technology developers. Contribute to pharmaceutical quality-related workshops or training for EU assessors and GMP inspectors.

Medicine 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 Best Sales Intelligence Tools For 2025

Spotio

In 2025, your success will depend on your ability to collect and analyze critical data. After extensive research, including reviews of real user feedback, weve compiled a comprehensive list of the top 10 sales intelligence tools for 2025. Sales intelligence tools have become essential for modern sales teams.

Sales 52
article thumbnail

EU regulators release new workplan for accelerating clinical research

European Pharmaceutical Review

implementing the CTR – focus on CTIS and CTR training activities and trouble-shooting any issues encountered by trial sponsors. establishing a multi-stakeholder platform to facilitate the evolution of the clinical trials environment through regular dialogue between all stakeholders, including patients, healthcare professionals and academia.

Medicine 105
article thumbnail

Takeda to invest €300 million in plasma-derived therapy production

European Pharmaceutical Review

Our Lessines site is an important part of our global manufacturing network. In addition to the investment in our production capacity, we also invest in the development and training of our employees to keep them abreast of the latest scientific, technical and digital evolutions.

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Its sustainability platform, fueled by its Health for Humanity 2025 Goals, contributes to the global effort to achieve a majority of the SDGs by supporting 11 of the 17, spanning the spheres of global health, social justice, environmental stewardship, and responsible business practices. Health for Humanity 2025 Goals. Sunny White.

Pharma 103
article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

Dr Boshoff will begin this new role on 1 January 2025 and will oversee all R&D functions across every therapeutic area in the company. He trained as medical oncologist at the Royal Marsden and Royal Free Hospitals in London. Furthermore, Dr Roger Dansey will become Interim Chief Oncology Officer, from 1 January 2025.